$LCTX Q2 '26 Earnings Results & Recap Lineage Cell Therapeutics reported total revenue of $1.1 million for the three months ended June 30, 2026, and $2.8 million for the six months ended June 30, 2026, respectively.
$LCTX Q2 '26 Earnings Results & Recap Lineage Cell Therapeutics reported total revenue of $1.1 million for the three months ended June 30, 2026, and $2.8 million for the six months ended June 30, 2026, respectively.